Doctor profile · Federal record
Dr. ANDREW BRUNNER, M.D.
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Internal Medicine Physician · BOSTON, MA
- NPI 1699095166
- Accepts Medicare
- 16 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
MASSACHUSETTS GENERAL HOSPITAL, 55 FRUIT ST.
BOSTON, MA 02114
(617) 726-2000
Credentials & registration
- NPI registered
- June 2010 — 16 yrs on file
- Profile last updated
- April 6, 2016
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Massachusetts #252646 · Massachusetts #L-243818
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1699095166. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
692
Distinct HCPCS
5
Medicare allowed
$87,395
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 274 | 56 | $126 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 230 | 63 | $104 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 146 | 50 | $153 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 23 | 22 | $184 | |
99239 |
Hospital discharge day management, more than 30 minutes | 19 | 19 | $123 |
In context: peer comparison
Among 64 peers in this city , average services per provider: 129. This provider delivers 5.4× the peer median.Open Payments
Industry payments received
All-time total
$18,783
Transactions
29
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Rigel Pharmaceuticals, Inc. | 7 | $9,920.41 | |
| SERVIER PHARMACEUTICALS LLC | 6 | $5,837.72 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $1,211.00 | |
| ABBVIE INC. | 1 | $675.00 | |
| AstraZeneca Pharmaceuticals LP | 4 | $453.68 | |
| TAIHO ONCOLOGY, INC. | 4 | $257.42 | |
| Daiichi Sankyo Inc. | 2 | $233.26 | |
| Astellas Pharma US Inc | 1 | $153.98 | |
| Celgene Corporation | 1 | $40.17 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
116
Patients
0
Total drug cost
$735,111
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Inqovi (Decitabine/Cedazuridine) | Brand | 36 | 0 | $305,244 |
| Acyclovir | Generic | 34 | 0 | $466 |
| Sprycel (Dasatinib) | Brand | 32 | 0 | $429,334 |
| Prochlorperazine Maleate | Generic | 14 | 0 | $67 |